What is sustained low‑efficiency daily diafiltration (SLEDD‑f) and when is it used in hemodynamically unstable ICU patients with acute kidney injury?

What is SLED-F?

SLED-F (Sustained Low-Efficiency Daily Diafiltration) is a hybrid renal replacement therapy that combines prolonged treatment duration (8-12 hours daily) with lower blood and dialysate flow rates than conventional hemodialysis, plus convective clearance through hemofiltration—making it an effective, cost-efficient alternative to continuous renal replacement therapy (CRRT) for hemodynamically unstable ICU patients with acute kidney injury. 1, 2

Technical Specifications

SLED-F operates with the following parameters:

• Blood flow: 5 mL/kg/min (approximately 200 mL/min) 3, 4
• Dialysate flow: 200-260 mL/min (much slower than conventional hemodialysis) 3, 4
• Hemofiltration rate: 35-100 mL/kg/hour 3, 4
• Treatment duration: 8-10 hours per session, delivered daily or at least on alternate days 4, 5
• Target delivered dose: Equivalent to 20-25 mL/kg/hour CRRT effluent volume 1, 2

The "diafiltration" component means it combines both diffusive clearance (dialysis) and convective clearance (filtration), providing superior removal of both small and larger solutes compared to dialysis alone 4, 5.

Clinical Applications

SLED-F should be used interchangeably with CRRT for hemodynamically unstable ICU patients with AKI, particularly when CRRT resources are limited. 1 The key indications include:

• Hemodynamically unstable patients requiring renal replacement therapy 1, 2
• Critically ill patients with AKI who cannot tolerate conventional intermittent hemodialysis 6, 7
• Resource-limited settings where CRRT equipment or trained personnel are unavailable 1, 5
• Situations requiring better hemodynamic stability than intermittent hemodialysis but without 24-hour CRRT infrastructure 8, 5

Advantages Over Other Modalities

SLED-F offers several practical benefits:

• Hemodynamic stability: Slower fluid and solute shifts prevent intradialytic hypotension (only 5% incidence) 3, 4
• Cost-effectiveness: Uses standard hemodialysis machines rather than dedicated CRRT equipment, reducing costs significantly 1, 5
• Resource efficiency: Can be delivered by ICU nursing staff autonomously without continuous nephrology presence 4
• Adequate clearance: Achieves Kt/V of 1.43 per treatment and equivalent renal urea clearance of 35.7 mL/min, meeting standards for both CRRT and intermittent hemodialysis 4
• Clinical outcomes: No survival advantage has been demonstrated for CRRT over SLED, with 30-day mortality rates comparable between modalities (54% SLED vs 61% CRRT) 1, 6

When CRRT is Preferred Over SLED-F

Despite its advantages, CRRT remains superior in specific high-risk scenarios:

• Acute brain injury with elevated intracranial pressure: CRRT's continuous, slower solute removal minimizes intracranial pressure fluctuations 1, 2
• Severe cerebral edema: Rapid osmotic shifts from intermittent therapies can worsen cerebral edema 1, 2
• Extreme hemodynamic instability: Patients requiring minute-to-minute fluid adjustments benefit from CRRT's continuous fine-tuning capability 1, 2

Practical Implementation Considerations

Vascular Access

• Use uncuffed, non-tunneled dialysis catheter in right internal jugular vein as first choice 1, 2
• Avoid subclavian vein placement due to stenosis risk 1, 2
• Obtain chest X-ray after jugular or subclavian placement before first session 1

Anticoagulation

• Regional citrate anticoagulation is first-line when anticoagulation is required 1, 2
• Heparin can be used safely (76.6% of sessions with no bleeding complications in one series) 3

Monitoring Requirements

• Check electrolytes every 2-6 hours initially, as SLED-F causes continuous losses of potassium, phosphate, magnesium, and amino acids 1
• Monitor delivered vs prescribed dose frequently—prescribe 20-25% higher than target to account for interruptions 1
• Therapeutic drug monitoring essential for dialyzable antibiotics (especially beta-lactams) 1

Nutritional Management

• Provide 1.5-1.7 g/kg/day protein once hemodynamically stable, accounting for 10-15 g daily amino acid losses 1
• Target 20-30 kcal/kg/day total energy intake 1
• Supplement water-soluble vitamins (thiamine, folate, vitamin C) to compensate for dialytic losses 1

Common Pitfalls

The main limitation of SLED-F is staffing availability—delivering 8-hour sessions six days per week requires dialysis personnel coverage that may not be feasible in all centers 1. Additionally, the prescribed dose often exceeds delivered dose due to treatment interruptions, so clinicians must monitor actual effluent volume and adjust prescriptions upward by 20-25% if targets are not met 1.